ArticleQuantitative imaging in medicine and surgery2025
Comparative study on the efficacy and safety of ultrasound-guided transluminal (transvaginal/transrectal) and transabdominal core needle biopsy in patients with pelvic masses: a retrospective analysis.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pelvic masses present diagnostic challenges due to their complex origins and non-specific imaging characteristics. The accurate preoperative evaluation of pelvic masses plays a crucial role in guiding clinical decision making. This study sought to compare the efficacy and safety of ultrasound (US)-guided transluminal (transvaginal/transrectal) and transabdominal core needle biopsy (CNB) in the diagnosis of pelvic masses. Methods: A retrospective cohort study was conducted of 305 patients with pelvic masses, who were divided into the following two groups based on the biopsy approach: the US-guided transabdominal CNB group (the transabdominal group) and the transvaginal/transrectal CNB group (the transluminal group). The biopsy time, intraoperative blood loss, diagnostic accuracy, incidence of complications, and postoperative pain levels were evaluated and compared between the two groups. Results: US-guided biopsy was successfully performed in 305 patients. There were no significant differences between the two groups in terms of accuracy (98.7% Conclusions: US-guided transluminal (transvaginal/transrectal) and transabdominal CNB have comparable diagnostic efficacy and safety for pelvic masses. Transvaginal or transrectal biopsy has substantial clinical value in the evaluation of deep pelvic masses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.